| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Isorhamnetin | Hepatic Fibrosis | 2 | PM | 37598299 | 📋 | Isorhamnetin Exerts Antifibrotic Effects by Attenuating Platelet-Derived Growth Factor-BB-induced HSC-T6 Cells Activation via Suppressing PI3K-AKT Signaling Pathway |
| Isorhamnetin | Hepatic Fibrosis | 1 | PM | 31467991 | 📋 | Antifibrotic Effect of Methylated Quercetin Derivatives on TGFβ-induced Hepatic Stellate Cells |
| Isorhamnetin | Hepatitis B | 1 | PM | 36185785 | 📋 | The anti‑hepatitis B virus activity of sea buckthorn is attributed to quercetin, kaempferol and isorhamnetin |
| Isorhamnetin | Hepatotoxicity | 1 | PM | 35359022 | 📋 | Therapeutic Potential of Isorhamnetin following Acetaminophen-Induced Hepatotoxicity through Targeting NLRP3/NF-κB/Nrf2 |
| Isorhamnetin | Liver Cancer | 2 | PM | 37226027 | 📋 | Isorhamnetin exerts anti-tumor activity in DEN + CCl4-induced HCC mice |
| Isorhamnetin | Liver Cancer | 1 | PM | 27522262 | 📋 | Structure related effects of flavonoid aglycones on cell cycle progression of HepG2 cells: Metabolic activation of fisetin and quercetin by catechol-O-methyltransferase (COMT) |
| Isorhamnetin | Liver Damage | 1 | PM | 24211276 | 📋 | Isorhamnetin protects against oxidative stress by activating Nrf2 and inducing the expression of its target genes |
